STUDY OF KEY STAKEHOLDERS FOR THEIR KNOWLEDGE, ATTITUDE AND PRACTICE ON ADVERSE DRUG REACTION REPORTING IN TERTIARY CARE HOSPITALS IN JAIPUR, INDIA

Adverse drug reactions (ADR) are the leading cause for the hospital administration, morbidity, and mortality as per the established data. Present pharmacovigilance program of India is performing well for strengthening ADR reporting system. The current project is aimed to study knowledge, attitude and practices of health care professionals and key stakeholders for adverse drug reaction reporting of marketed medicines. The study was conducted in four major tertiary care hospitals in Jaipur from government and private sector from May to July 2015. The data was collected from key stakeholders with a sample size of 1022 (male & female of age group 18-70 years) using a semi structured questionnaire tool separate for different segment of the key stakeholders. Data was cleaned and analysed for its descriptive report and assessment of the situation. There is less aware of the adverse drug reaction reporting system, only 32% of the doctor's sample is aware about the reporting system of adverse drug reaction in India as well as the mandatory time period in case of serious adverse drug reaction reporting (26%). The location for regional office for adverse drug reaction reporting is known to only 26% of the sampled doctors in all the major four tertiary care hospitals of Jaipur. It is found that the awareness about ‘To whom adverse drug reaction should be reported' is seen in only 12% of the sample doctors. While only 6% of them are provided any training about the adverse drug reaction reporting procedure. It was found that only 57% of the sampled doctors had encountered patients with adverse drug reaction in their clinical practice during last one year of the study, and only 45% of them are recording adverse drug reactions in their record book or file. It was found that although the health professionals are aware of the basic knowledge about the adverse drug reaction due involvement of key terms in their basic education and training, there is a huge gap found in knowledge parameter as seen in unawareness about the reporting system of Pharmacovigilance.